These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9525837)

  • 41. Imaging of P glycoprotein function in vivo with PET.
    Hendrikse NH; Vaalburg W
    Novartis Found Symp; 2002; 243():137-45; discussion 145-8, 180-5. PubMed ID: 11990773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cyclosporin A inhibits the extrusion pump function of p-glycoprotein in the inner ear of mice treated with vinblastine and doxorubicin.
    Saito T; Zhang ZJ; Tokuriki M; Ohtsubo T; Shibamori Y; Yamamoto T; Saito H
    Brain Res; 2001 May; 901(1-2):265-70. PubMed ID: 11368976
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclosporin A is a broad-spectrum multidrug resistance modulator.
    Qadir M; O'Loughlin KL; Fricke SM; Williamson NA; Greco WR; Minderman H; Baer MR
    Clin Cancer Res; 2005 Mar; 11(6):2320-6. PubMed ID: 15788683
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic interaction between cyclosporine and sirolimus.
    Bai S; Stepkowski SM; Kahan BD; Brunner LJ
    Transplantation; 2004 May; 77(10):1507-12. PubMed ID: 15239612
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New Tetrahydroisoquinoline Derivatives Overcome Pgp Activity in Brain-Blood Barrier and Glioblastoma Multiforme in Vitro.
    Salaroglio IC; Gazzano E; Kopecka J; Chegaev K; Costamagna C; Fruttero R; Guglielmo S; Riganti C
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29890725
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of cyclosporin A or tacrolimus on the function of blood-brain barrier cells.
    Kochi S; Takanaga H; Matsuo H; Naito M; Tsuruo T; Sawada Y
    Eur J Pharmacol; 1999 May; 372(3):287-95. PubMed ID: 10395024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter, P-glycoprotein.
    Tsuji A; Tamai I; Sakata A; Tenda Y; Terasaki T
    Biochem Pharmacol; 1993 Sep; 46(6):1096-9. PubMed ID: 8105783
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of cyclosporin A on the brain regional distribution of doxorubicin in rats.
    Hsieh YJ; Chang CH; Huang SP; Lin CW; Wang MN; Wu YT; Chen YJ; Tsai TH
    Int J Pharm; 2008 Feb; 350(1-2):265-71. PubMed ID: 17935917
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclosporins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC transporter.
    Loor F; Tiberghien F; Wenandy T; Didier A; Traber R
    J Med Chem; 2002 Oct; 45(21):4598-612. PubMed ID: 12361387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. P-glycoprotein in HK-2 proximal tubule cell line.
    Tramonti G; Romiti N; Norpoth M; Chieli E
    Ren Fail; 2001; 23(3-4):331-7. PubMed ID: 11499549
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Upregulation of brain expression of P-glycoprotein in MRP2-deficient TR(-) rats resembles seizure-induced up-regulation of this drug efflux transporter in normal rats.
    Hoffmann K; Löscher W
    Epilepsia; 2007 Apr; 48(4):631-45. PubMed ID: 17437408
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical trials of modulation of multidrug resistance. Pharmacokinetic and pharmacodynamic considerations.
    Lum BL; Fisher GA; Brophy NA; Yahanda AM; Adler KM; Kaubisch S; Halsey J; Sikic BI
    Cancer; 1993 Dec; 72(11 Suppl):3502-14. PubMed ID: 7902206
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemosensitization of human hepatocellular carcinoma cells with cyclosporin A in post-liver transplant patient plasma.
    Tong AW; Su D; Mues G; Tillery GW; Goldstein R; Klintmalm G; Stone MJ
    Clin Cancer Res; 1996 Mar; 2(3):531-9. PubMed ID: 9816200
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistance.
    Vredenburg MR; Ojima I; Veith J; Pera P; Kee K; Cabral F; Sharma A; Kanter P; Greco WR; Bernacki RJ
    J Natl Cancer Inst; 2001 Aug; 93(16):1234-45. PubMed ID: 11504769
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential effects of mitomycin C and doxorubicin on P-glycoprotein expression.
    Maitra R; Halpin PA; Karlson KH; Page RL; Paik DY; Leavitt MO; Moyer BD; Stanton BA; Hamilton JW
    Biochem J; 2001 May; 355(Pt 3):617-24. PubMed ID: 11311122
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A mechanism for overcoming P-glycoprotein-mediated drug resistance: novel combination therapy that releases stored doxorubicin from lysosomes via lysosomal permeabilization using Dp44mT or DpC.
    Seebacher NA; Richardson DR; Jansson PJ
    Cell Death Dis; 2016 Dec; 7(12):e2510. PubMed ID: 27906178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multidrug resistance-reversing agents increase vinblastine distribution in normal tissues expressing the P-glycoprotein but do not enhance drug penetration in brain and testis.
    Arboix M; Paz OG; Colombo T; D'Incalci M
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1226-30. PubMed ID: 9190857
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Duration and degree of cyclosporin induced P-glycoprotein inhibition in the rat blood-brain barrier can be studied with PET.
    Syvänen S; Blomquist G; Sprycha M; Höglund AU; Roman M; Eriksson O; Hammarlund-Udenaes M; Långström B; Bergström M
    Neuroimage; 2006 Sep; 32(3):1134-41. PubMed ID: 16857389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. P-glycoprotein and breast cancer resistance protein expression and function at the blood-brain barrier and blood-cerebrospinal fluid barrier (choroid plexus) in streptozotocin-induced diabetes in rats.
    Reichel V; Burghard S; John I; Huber O
    Brain Res; 2011 Jan; 1370():238-45. PubMed ID: 21075088
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
    Rieger L; Rieger J; Winter S; Streffer J; Esser P; Dichgans J; Meyermann R; Weller M
    Acta Neuropathol; 2000 May; 99(5):555-62. PubMed ID: 10805101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.